Skip to main content
. Author manuscript; available in PMC: 2017 May 15.
Published in final edited form as: J Immunol. 2016 Apr 18;196(10):4040–4051. doi: 10.4049/jimmunol.1502276

TABLE I.

Demographics of study participants

De novo AIH
(n=21)
LTC
(n=27)
HC
(n=28)
P value
Age at blood
draw
mean ± SD
(years)
14.87 ± 4.60 10.48 ± 6.24 8.98 ± 5.28 HC vs. LTC 0.3
HC vs. DAIH 0.002
LTC vs. DAIH 0.04
Gender (m/f) 11/10 18/9 13/15 0.3
Duration from
transplant at
blood draw
mean ± SD
(days)
4149.76 ±
1938.75
3261.80 ±
2363.39
n/a 0.2
Duration from
transplant at
de novo
diagnosis mean
± SD (days)
2142.65 ±
1175.85
n/a n/a
Pre transplant
diagnosis:
Biliary atresia
Other
13
8
17
10
n/a 0.9
CNI trough level
at blood draw
mean ± SD ( )
4.74 ± 1.88 3.39 ± 2.75 n/a 0.2

AIH: Autoimmune hepatitis

LTC: Liver transplanted control

HC: Healthy control

CNI: Calcineurin inhibitor